1/26/2006

Merck's CEO said the firm is looking at the biotech industry's larger companies as possible takeover targets, with a focus on companies that could contribute late-stage products and revenue. Richard Clark added Merck will continue to consider forming alliances and buying marketing rights from biotechs.

Related Summaries